Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan, TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan and Datopotamab.
CAS号
2267989-53-5
运输条件
Room temperature in continental US; may vary elsewhere.